Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes

PURPOSE: Previous research suggests that treatment process can have an influence on patient preference and health state utilities. This study examined preferences and estimated utilities for treatment processes of two daily oral treatment regimens and two weekly injectable regimens for treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Matza, Louis S., Cutts, Katelyn N., Stewart, Katie D., Norrbacka, Kirsi, García-Pérez, Luis-Emilio, Boye, Kristina S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233232/
https://www.ncbi.nlm.nih.gov/pubmed/33886044
http://dx.doi.org/10.1007/s11136-021-02808-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233232/
https://www.ncbi.nlm.nih.gov/pubmed/33886044
http://dx.doi.org/10.1007/s11136-021-02808-2

Ejemplares similares